Health Canada technical amendments to regulations

Summary#

These are final, mostly technical amendments made by Health Canada under instrument SOR/2023-247. They correct wording and translation issues, clarify some reporting and labelling rules (including for some veterinary drugs and vaping containers), and update a few referenced standards. The changes came into force on November 24, 2023.

What it does#

• Fixes wording, typos and translation mismatches across several health-related regulations to make the English and French texts match and to reduce confusion. This affects multiple rules rather than creating new policy.
• Amends the Food and Drug Regulations to:
  • Clarify reporting rules and add a timing requirement for annual reports about certain veterinary drugs that contain active ingredients on List A (reports cover a calendar year and must be filed by March 31 of the following year).
  • Change some wording so decisions about experimental study certificates are based on whether the Minister “determines” that requirements are not met (reducing subjective language).
  • Harmonize label-direction wording (e.g., replace “suitable” with “adequate”).
  • Make small wording and cross-reference clarifications (including storage wording).
• Updates wording in the Medical Devices Regulations to clarify which investigation is being referenced and to fix a French wording error.
• Changes the Natural Health Products Regulations so emergency provisions apply more clearly to natural health products (limits those authorizations to human use and aligns the terminology for adverse reactions).
• Amends the Vaping Products Labelling and Packaging Regulations and the Vaping Products Promotion Regulations to standardize French terms (replacing “mise en garde” with “avertissement sanitaire”) and to give more flexible labelling options for very small vaping containers (rules now reference main display panel sizes 15 cm2 and 45 cm2).
• Updates test standards in the Glazed Ceramics and Glassware Regulations to the newer editions: ISO 6486-1:2019 and ASTM C927-80 (2019).
• Corrects the French name for a chemical (hypophosphorous acid) in the schedules to the Precursor Control Regulations and to Schedule VI of the Controlled Drugs and Substances Act.
• Clarifies storage and transportation wording in the Safety of Human Cells, Tissues and Organs for Transplantation Regulations and improves a monitoring requirement.
• Renumbers or tweaks small paragraph labels and punctuation to improve readability and consistency across the affected regulations.
• The amendments are described by Health Canada as non-substantive and administrative; they do not add new fees or new regulatory obligations beyond clarifications.

Who's affected#

• Manufacturers, importers and distributors of veterinary drugs that contain certain antimicrobial ingredients (those on List A), because of the clarified annual reporting timeline.
• Producers and sellers of vaping products, especially those using very small containers (packagers, marketers and retailers), because of the relaxed display options for small immediate containers.
• Medical device makers and firms involved with human cells, tissues or organs (storage and documentation wording clarified).
• Businesses and labs that sell or test glazed ceramics and glassware, because of the updated test standards (ISO 6486-1:2019, ASTM C927-80 (2019)).
• Companies dealing with precursor chemicals subject to the Precursor Control Regulations and the Controlled Drugs and Substances Act schedule, because a French name was corrected.
• In general, regulated parties who rely on exact wording or cross-references in the listed regulations may notice the changes.
• Health Canada says these are administrative corrections and that the changes do not increase burdens on small businesses.

Why it matters#

• Clearer wording and matching English/French texts reduce the risk that businesses, regulators or courts interpret the same rule differently. That makes compliance simpler and lowers the chance of accidental non‑compliance.
• The reporting deadline for certain veterinary antimicrobial drugs (annual report by March 31) gives manufacturers and veterinarians a clear date to plan for.
• The vaping container labelling tweaks give manufacturers more practical labelling options for very small packages, helping information actually fit on products while keeping required warnings available.
• Updating test standards brings Canada’s rules in line with more recent international testing methods for lead and cadmium release from ceramics and glass.
• Overall, these are mostly technical, non‑policy changes meant to reduce confusion and improve consistency; they do not introduce major new obligations or costs according to Health Canada.